Ainos (NASDAQ:AIMD) is showcasing its breakthrough AI Nose technology at COMPUTEX 2025 in partnership with ugo, Japan's leading service robotics company. The AI Nose platform represents a significant advancement in robotic olfaction, utilizing MEMS gas sensor arrays and machine learning to digitize scents into Smell IDs. The technology achieves 99% accuracy in model development, with 90% accuracy in healthcare applications and 80% in semiconductor environments. The electronic nose market is projected to reach $76.5 billion by 2032. The demonstration at COMPUTEX 2025, themed "AI Next," will showcase AI-powered scent digitization applications in smart infrastructure, elder care, and industrial safety at Booth InnoVEX S0324 at Taipei Nangang Exhibition Center.
Ainos (NASDAQ:AIMD) presenta la sua innovativa tecnologia AI Nose al COMPUTEX 2025 in collaborazione con ugo, la principale azienda giapponese di robotica di servizio. La piattaforma AI Nose rappresenta un importante progresso nell'olfazione robotica, utilizzando array di sensori di gas MEMS e apprendimento automatico per digitalizzare gli odori in Smell ID. La tecnologia raggiunge una precisione del 99% nello sviluppo del modello, con una precisione del 90% nelle applicazioni sanitarie e dell'80% negli ambienti dei semiconduttori. Il mercato del naso elettronico è previsto raggiungere 76,5 miliardi di dollari entro il 2032. La dimostrazione al COMPUTEX 2025, con il tema "AI Next", mostrerà applicazioni di digitalizzazione degli odori basate sull'intelligenza artificiale per infrastrutture intelligenti, assistenza agli anziani e sicurezza industriale presso lo stand InnoVEX S0324 al Taipei Nangang Exhibition Center.
Ainos (NASDAQ:AIMD) presenta su innovadora tecnología AI Nose en COMPUTEX 2025, en colaboración con ugo, la principal empresa japonesa de robótica de servicio. La plataforma AI Nose representa un avance significativo en la olfacción robótica, utilizando matrices de sensores de gas MEMS y aprendizaje automático para digitalizar los olores en Smell IDs. La tecnología alcanza una precisión del 99% en el desarrollo del modelo, con una precisión del 90% en aplicaciones de salud y del 80% en entornos de semiconductores. Se proyecta que el mercado de narices electrónicas alcanzará los 76,5 mil millones de dólares para 2032. La demostración en COMPUTEX 2025, bajo el tema "AI Next", mostrará aplicaciones de digitalización de olores impulsadas por IA en infraestructura inteligente, cuidado de personas mayores y seguridad industrial en el stand InnoVEX S0324 en el Taipei Nangang Exhibition Center.
Ainos(NASDAQ:AIMD)는 일본의 선도적인 서비스 로봇 회사 ugo와 협력하여 COMPUTEX 2025에서 획기적인 AI Nose 기술을 선보입니다. AI Nose 플랫폼은 MEMS 가스 센서 배열과 머신러닝을 활용해 냄새를 Smell ID로 디지털화하는 로봇 후각 분야의 중요한 진전을 나타냅니다. 이 기술은 모델 개발에서 99%의 정확도를 달성했으며, 의료 분야에서는 90%, 반도체 환경에서는 80%의 정확도를 보입니다. 전자 코 시장은 2032년까지 765억 달러에 이를 것으로 예상됩니다. COMPUTEX 2025의 'AI Next' 테마 아래, 타이페이 난강 전시장 InnoVEX S0324 부스에서 스마트 인프라, 노인 돌봄, 산업 안전 분야에 AI 기반 냄새 디지털화 응용을 시연할 예정입니다.
Ainos (NASDAQ:AIMD) présente sa technologie révolutionnaire AI Nose au COMPUTEX 2025 en partenariat avec ugo, la principale entreprise japonaise de robotique de service. La plateforme AI Nose représente une avancée majeure dans l'olfaction robotique, utilisant des réseaux de capteurs de gaz MEMS et l'apprentissage automatique pour numériser les odeurs en Smell IDs. La technologie atteint une précision de 99 % dans le développement du modèle, avec une précision de 90 % dans les applications de santé et de 80 % dans les environnements semi-conducteurs. Le marché du nez électronique devrait atteindre 76,5 milliards de dollars d'ici 2032. La démonstration au COMPUTEX 2025, sous le thème « AI Next », présentera des applications de numérisation des odeurs alimentées par l'IA dans les infrastructures intelligentes, les soins aux personnes âgées et la sécurité industrielle au stand InnoVEX S0324 au Taipei Nangang Exhibition Center.
Ainos (NASDAQ:AIMD) präsentiert seine bahnbrechende AI Nose-Technologie auf der COMPUTEX 2025 in Zusammenarbeit mit ugo, Japans führendem Service-Robotikunternehmen. Die AI Nose-Plattform stellt einen bedeutenden Fortschritt in der robotischen Geruchserkennung dar und nutzt MEMS-Gassensorarrays und maschinelles Lernen, um Düfte in Smell IDs zu digitalisieren. Die Technologie erreicht 99 % Genauigkeit bei der Modellentwicklung, mit 90 % Genauigkeit in medizinischen Anwendungen und 80 % in Halbleiterumgebungen. Der Markt für elektronische Nasen wird bis 2032 voraussichtlich 76,5 Milliarden US-Dollar erreichen. Die Demonstration auf der COMPUTEX 2025 mit dem Thema „AI Next“ zeigt KI-gestützte Anwendungen zur Duftdigitalisierung in intelligenter Infrastruktur, Altenpflege und Industriesicherheit am Stand InnoVEX S0324 im Taipei Nangang Exhibition Center.
Positive
None.
Negative
None.
Robotic Smell Intelligence Goes Live at Asia's Premier AI Tech Stage
SAN DIEGO, CA / ACCESS Newswire / May 22, 2025 / Ainos, Inc. (NASDAQ:AIMD)(Nasdaq:AIMDW) ("Ainos"), a pioneer in AI-driven scent digitization, announced the official debut of its proprietary AI Nose platform at COMPUTEX 2025, alongside ugo, Inc, Japan's top service robotics company. This milestone marks the first public demonstration of real-time robotic olfaction-a new sensory category poised to transform smart robotics, environmental AI, and safety infrastructure.
This year's COMPUTEX theme, "AI Next," positions Ainos and its partners at the center of a global shift where AI expands beyond sight and sound-into scent, the final frontier of machine perception.
Smell: The Next AI Token
AI Nose, first developed for healthcare and now expanding its use into robotics and smart manufacturing, digitizes scent into Smell IDs using MEMS gas sensor arrays and machine learning models built on 13 years of deep research. Inside Ainos' AI lab, engineers train these Smell IDs through deep learning, achieving over 99% accuracy during initial model development. In live deployments, AI Nose delivers approximately 90% accuracy in healthcare and 80% in semiconductor environments. This Smelltech transforms invisible chemical signals into real-time, actionable insights, enabling robots and edge AI systems to detect safety threats, hygiene issues, and diagnostic markers that traditional sensors miss.
The electronic nose (e-nose) market is projected to grow to $76.5 billion by 2032, driven by demand in robotics, industrial monitoring, healthcare, and environmental sensing. Ainos' AI Nose platform is strategically positioned to capture leadership in this expanding SmellTech frontier, through partnerships with the world's largest semiconductor packaging and testing company and ugo, Japan's service robotics company.
At COMPUTEX 2025, ugo and Ainos are revealing the industry-leading robotic system with SmellTech, showcasing AI-powered scent digitization for smart infrastructure, elder care, and industrial safety applications. Visit Booth InnoVEX S0324 at Taipei Nangang Exhibition Center, Hall 2 (TaiNEX 2).
"We are giving machines a new sense-the power to smell-and that changes everything," said Chun-Hsien (Eddy) Tsai, CEO of Ainos. "At COMPUTEX 2025, we are not just showing a new product-we're unlocking an entirely new category of machine intelligence. As the global tech community converges around 'AI Next,' Ainos is leading the charge by opening up smell as a new signal for AI models, real-world robotics, and edge computing infrastructure."
About Ainos, Inc.
Headquartered in San Diego, California, Ainos, Inc. develops disruptive medical and healthcare solutions based on its proprietary AI Nose and VELDONA® technologies. The name "Ainos" combines "AI" and "Nose" to signify the Company's commitment to enabling AI with the ability to smell and individuals to live healthier. The Company's clinical-stage product pipeline includes AI-driven, telehealth-friendly POCT solutions powered by AI Nose, VELDONA® human and animal oral therapeutics, and human orphan drugs. To learn more, visit https://www.ainos.com. Follow Ainos on X, formerly known as Twitter, (@AinosInc) and LinkedIn to stay up-to-date.
About COMPUTEX 2025
COMPUTEX 2025, held from May 20 to May 23 at the Taipei Nangang Exhibition Center, is Asia's premier technology exhibition, featuring over 1,400 exhibitors from 34 countries. This year's theme, "AI Next," focuses on the integration of artificial intelligence in next-generation technologies, including robotics, smart computing, and future mobility.
Forward-Looking Statements
Certain statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements are based on management's current assumptions and expectations of future events and trends, which affect or may affect the Company's business, strategy, operations or financial performance, and actual results and other events may differ materially from those expressed or implied in such statements due to numerous risks and uncertainties. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. There are a number of important factors that could cause actual results, developments, business decisions or other events to differ materially from those contemplated by the forward-looking statements in this press release. These factors include, among other things, our expectation that we will incur net losses for the foreseeable future; our ability to become profitable; our ability to raise additional capital to continue our product development; our ability to accurately predict our future operating results; our ability to advance our current or future product candidates through clinical trials, obtain marketing approval and ultimately commercialize any product candidates we develop; the ability to obtain and maintain regulatory approval of our product candidates; delays in completing the development and commercialization of our current and future product candidates; developing and commercializing additional products, including diagnostic testing devices; our ability to compete in the marketplace; compliance with applicable laws, regulations and tariffs, and factors described in the Risk Factors section of our public filings with the Securities and Exchange Commission (SEC). Because forward-looking statements are inherently subject to risks and uncertainties, you should not rely on these forward-looking statements as predictions of future events. These forward-looking statements speak only as of the date of this press release and, except to the extent required by applicable law, the Company undertakes no obligation to update or revise these statements, whether as a result of any new information, future events and developments or otherwise.
What is Ainos (AIMD) AI Nose technology and how does it work?
Ainos' AI Nose technology digitizes scents into Smell IDs using MEMS gas sensor arrays and machine learning models. It achieves 99% accuracy in model development, 90% accuracy in healthcare applications, and 80% in semiconductor environments.
What is the market potential for Ainos (AIMD) electronic nose technology?
The electronic nose (e-nose) market is projected to grow to $76.5 billion by 2032, driven by demand in robotics, industrial monitoring, healthcare, and environmental sensing.
Where is Ainos (AIMD) showcasing its AI Nose technology at COMPUTEX 2025?
Ainos is showcasing its AI Nose technology at Booth InnoVEX S0324 at Taipei Nangang Exhibition Center, Hall 2 (TaiNEX 2), in partnership with ugo, Japan's service robotics company.
What are the main applications of Ainos (AIMD) AI Nose technology?
The AI Nose technology is being applied in healthcare, robotics, smart manufacturing, smart infrastructure, elder care, and industrial safety applications for detecting safety threats, hygiene issues, and diagnostic markers.
An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
